| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |